ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Cellcentric Limited

Cellcentric Limited is an active company incorporated on 30 October 2003 with the registered office located in Saffron Walden, Essex. Cellcentric Limited was registered 21 years ago.
Status
Active
Active since 21 years ago
Company No
04948632
Private limited company
Age
21 years
Incorporated 30 October 2003
Size
Unreported
Confirmation
Submitted
Dated 13 May 2025 (5 months ago)
Next confirmation dated 13 May 2026
Due by 27 May 2026 (7 months remaining)
Last change occurred 4 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Small
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
Chesterford Research Park
Little Chesterford
Cambridge
CB10 1XL
Address changed on 23 Jul 2024 (1 year 3 months ago)
Previous address was
Telephone
01799531130
Email
Available in Endole App
People
Officers
9
Shareholders
1
Controllers (PSC)
2
Secretary • Director • Accountant • British • Lives in England • Born in May 1961
Director • British • Lives in UK • Born in Jul 1968
Director • None • Dutch • Lives in Netherlands • Born in Jan 1975
Director • Research Director • British • Lives in UK • Born in Oct 1962
Director • Non Exec Director • British • Lives in England • Born in Apr 1964
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
F2G Ltd
Dr William Henry Lewarne West is a mutual person.
Active
Warneswest Ltd
Dr William Henry Lewarne West is a mutual person.
Active
Cyted UK Ltd
Dr William Henry Lewarne West is a mutual person.
Active
Cyted Ltd
Dr William Henry Lewarne West is a mutual person.
Active
Cyted Health Ltd
Dr William Henry Lewarne West is a mutual person.
Active
Vaxequity Ltd
Dr William Henry Lewarne West is a mutual person.
Dissolved
Brands
CellCentric
CellCentric is a clinical stage biotech company focused on the development of a p300/CBP inhibitor to treat specific cancer types, notably multiple myeloma.
Financials
Net Assets, Total Assets & Total Liabilities (2016–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£38.42M
Increased by £14.49M (+61%)
Turnover
Unreported
Same as previous period
Employees
19
Decreased by 1 (-5%)
Total Assets
£41.05M
Increased by £15.62M (+61%)
Total Liabilities
-£3.33M
Decreased by £21.33M (-86%)
Net Assets
£37.72M
Increased by £36.94M (+4779%)
Debt Ratio (%)
8%
Decreased by 88.85% (-92%)
Latest Activity
Small Accounts Submitted
20 Days Ago on 2 Oct 2025
Confirmation Submitted
4 Months Ago on 10 Jun 2025
Thea Sarah Stanway Resigned
4 Months Ago on 3 Jun 2025
Dr Jasper Bos Appointed
4 Months Ago on 3 Jun 2025
Small Accounts Submitted
1 Year 2 Months Ago on 22 Aug 2024
Registers Moved To Inspection Address
1 Year 3 Months Ago on 23 Jul 2024
Inspection Address Changed
1 Year 3 Months Ago on 23 Jul 2024
Dr Irena Melnikova Appointed
1 Year 3 Months Ago on 11 Jul 2024
Laura Smith Appointed
1 Year 3 Months Ago on 11 Jul 2024
Neil Anthony Pegg Resigned
1 Year 4 Months Ago on 7 Jun 2024
Get Credit Report
Discover Cellcentric Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital following an allotment of shares on 3 October 2025
Submitted on 14 Oct 2025
Memorandum and Articles of Association
Submitted on 6 Oct 2025
Accounts for a small company made up to 31 December 2024
Submitted on 2 Oct 2025
Resolutions
Submitted on 30 Sep 2025
Termination of appointment of Thea Sarah Stanway as a director on 3 June 2025
Submitted on 16 Jun 2025
Appointment of Dr Jasper Bos as a director on 3 June 2025
Submitted on 16 Jun 2025
Memorandum and Articles of Association
Submitted on 10 Jun 2025
Resolutions
Submitted on 10 Jun 2025
Confirmation statement made on 13 May 2025 with updates
Submitted on 10 Jun 2025
Statement of capital following an allotment of shares on 22 April 2025
Submitted on 6 Jun 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year